Shedding Light On Aromatase Inhibitor Joint Pain Syndrome

Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors (AIs) if they have advanced stage cancer, according to a study presented at the American College of Rheumatology's annual meeting, held Nov. 7-11, in Atlanta. The study is one of the first to identify factors that increase the likelihood that a patient will suffer joint pain from AI therapy...

Source: http://www.medicalnewstoday.com/releases/207179.php

ADVANCED MICRO DEVICES, INC. SYMANTEC CORP AFFILIATED COMPUTER SERVICES, INC. UNISYS CORP